Research, ventures, and the people moving Duke innovation forward.
83°FResearch, ventures, and the people moving Duke innovation forward.
Breakthroughs
Research discoveries and scientific and clinical wins from Duke.
Breakthroughs
Research discoveries and scientific and clinical wins from Duke.
Breakthroughs
Research discoveries and scientific and clinical wins from Duke.
Breakthroughs
View MoreA quick eye scan in the NICU may predict brain development in premature infants, Duke study finds
A Duke University School of Medicine study published in JAMA Ophthalmology found that a noninvasive retinal scan performed on very preterm infants in the NICU can predict cognitive, motor, and behavioral outcomes at age 2, potentially enabling earlier intervention for developmental delays.
Breakthroughs
View MoreDuke researcher says glucagon, not just GLP-1, may be driving obesity drugs' record weight loss results
Duke's Jonathan Campbell presented evidence at ADA 2026 that glucagon, not just GLP-1, may be a key driver behind the remarkable efficacy of triple-agonist obesity drugs like retatrutide, which produced up to 30% body weight loss in Phase 3 trials.
Breakthroughs
View MoreDuke researchers discover how two proteins manage hundreds of drug targets
Duke School of Medicine researchers published a Nature study showing that β-arrestin proteins form liquid-like droplet clusters that regulate G protein-coupled receptors, the targets of one-third of FDA-approved drugs, potentially pointing toward new approaches in drug design.
©2026 Duke Innovation Digest
Powered by Surround Sound Media
©2026 Duke Innovation Digest
Powered by Surround Sound Media
©2026 Duke Innovation Digest
Powered by Surround Sound Media